Browsing by Sponsor/Funder IP2IPO Innovations Limited

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
23-Oct-2020Doxorubicin improves cancer cell targeting by filamentous phage gene delivery vectors.Tsafa, E; Bentayebi, K; Topanurak, S; Yata, T; Przystal, J, et al
9-May-2019Exploitation of antibiotic resistance as a novel drug target: development of a β-lactamase-activated antibacterial prodrug.Evans, LE; Krishna, A; Ma, Y; Webb, TE; Marshall, DC, et al
Jun-2019Meta-analyses identify differentially expressed microRNAs in Parkinson's diseaseSchulz, J; Takousis, P; Wohlers, I; Itua, IOG; Dobricic, V, et al
15-Jun-2016Neurophenotypes in airway diseases: insights from translational cough studiesBelvisi, MG; Birrell, MA; Khalid, S; Wortley, MA; Dockry, R, et al
14-Jul-2021Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancerPardo, O; Chrysostomou, S; Roy, R; Prischi, F; Thamlikitkul, L, et al
18-Jul-2022RFTacho: Non-intrusive RF monitoring of rotating machinesHeggo, M; Bhatia, L; McCann, J; , et al
23-Nov-2021Targeting human osteoarthritic chondrocytes with ligand directed bacteriophage-based particlesChongchai, A; Waramit, S; Wongwichai, T; Kampangtip, J; Phitak, T, et al
13-Jun-2019The Popeye domain containing gene family encoding a family of cAMP-effector proteins with important functions in striated muscle and beyondSwan, A; Gruscheski, L; Boland, L; Brand, T; , et al